Colgate-Palmolive in the news

Colgate-Palmolive's Q4 revenue is expected to rise slightly with lower profits, amid a broader market update on Q4 earnings from multiple companies.

Colgate-Palmolive cuts earnings outlook as economic worries lead consumers to buy less toothpaste and soap.

Panagora Asset Management increased its stake in Colgate-Palmolive, which reported slightly better-than-expected Q2 earnings and maintains a moderate buy analyst consensus with a 2.5% dividend yield.

Colgate Palmolive (India) saw a 2.04% share price drop amid mixed financial results showing increased annual sales and profit but declining quarterly performance and negative cash flow.

Procter & Gamble leads with a broad consumer goods portfolio and premiumization strategy, while Colgate-Palmolive dominates oral care and focuses on specialization and digital growth.

Colgate-Palmolive faces weak technicals and mixed analyst signals, with cautious investor sentiment and stable but somewhat risky fundamentals.

Coca-Cola, Altria Group, McCormick, Colgate-Palmolive, and Hershey are identified as money-printing machines for their consistent dividend payments and strategic business adjustments to ensure continued cash flow.

Wells Fargo lowered its price target for Colgate-Palmolive to USD 90, despite a Q2 2026 revenue increase, due to a decline in net income, with Q3 results expected on October 30, 2026.

Institutional investors are increasing their stake in Colgate-Palmolive, which reported strong Q2 earnings, announced a dividend, and saw some insider stock sales.

Neville Rodie & Shaw Inc. significantly increased its stake in Colgate-Palmolive, which reported strong Q3 earnings, declared a dividend, and saw insider stock sales.

Wells Fargo adjusted its price target for Colgate-Palmolive to $90 from $95 while maintaining an Equalweight rating.

Wells Fargo lowered its price target for Colgate-Palmolive to $90 due to mixed Q2 2026 results showing sales growth but margin pressure.

Ferguson Wellman Capital Management Inc. significantly increased its shares in Colgate-Palmolive, which reported strong earnings, declared a dividend, and saw updated analyst price targets.

Wells Fargo maintained an Equal-Weight rating for Colgate-Palmolive while lowering its price target to $90, reflecting a cautious outlook due to changing market conditions.

Colgate-Palmolive reported a 4.9% increase in Q2 2026 net sales and an adjusted EPS of $0.99, exceeding estimates, despite a GAAP EPS decline.

Colgate-Palmolive shows dividend sustainability with a 2.42% yield and a strong GF Score of 84, despite recent insider selling, making it an attractive income stock according to GuruFocus.

Institutional investors increased their holdings in Colgate-Palmolive Company, while some insiders sold shares.

Colgate-Palmolive's stock saw a slight after-hours decline to EUR 75.33, while the company declared a quarterly cash dividend of USD 0.53 per common share.

Colgate-Palmolive (CL) received a "Moderate Buy" rating with a $98.94 target, reported strong Q2 earnings, declared a dividend, and saw insider stock sales.